Cite
Siponimod (BAF312) Treatment Reduces Brain Infiltration but Not Lesion Volume in Middle-Aged Mice in Experimental Stroke
MLA
Grazyna Domanska, et al. “Siponimod (BAF312) Treatment Reduces Brain Infiltration but Not Lesion Volume in Middle-Aged Mice in Experimental Stroke.” Stroke, vol. 50, May 2019, pp. 1224–31. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9a0feb52fe555a0419dc1c5e7ee5d255&authtype=sso&custid=ns315887.
APA
Grazyna Domanska, Michael Kirsch, Juliane Schulze, Johanna Ruhnau, Antje Vogelgesang, & Alexander Dressel. (2019). Siponimod (BAF312) Treatment Reduces Brain Infiltration but Not Lesion Volume in Middle-Aged Mice in Experimental Stroke. Stroke, 50, 1224–1231.
Chicago
Grazyna Domanska, Michael Kirsch, Juliane Schulze, Johanna Ruhnau, Antje Vogelgesang, and Alexander Dressel. 2019. “Siponimod (BAF312) Treatment Reduces Brain Infiltration but Not Lesion Volume in Middle-Aged Mice in Experimental Stroke.” Stroke 50 (May): 1224–31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9a0feb52fe555a0419dc1c5e7ee5d255&authtype=sso&custid=ns315887.